Key Features: Copper-binding peptide promoting cellular regeneration and repair
Ethics statement The studies involving human participants were reviewed and approved by Institutional Review Board at Nova Southeastern University in Fort Lauderdale, FL, USA
Wang L, Zhang J, Sun H, Ji X, Zhang S
Current Access Options for BPC-157 While BPC-157 transitions through the regulatory process, patients may have several options depending on their location and healthcare provider: 503A compounding pharmacies: Some state-licensed pharmacies may still compound BPC-157 depending on their state's regulations and interpretation of the current federal guidance
Taken together, these studies contributed greatly towards the translational application of IgG Fc engineering to alter the Fc:FcRn interaction, and provided further proof of the specificity and pH dependency of the interaction